Forbes August 19, 2020
Covid-19 has opened Americans’ eyes to a number of oft overlooked healthcare issues. It showed us how vulnerable our pharmaceutical supply chain is. It reminded us why we must start taking behavioral health seriously. It reemphasized the importance of addressing social determinants of health. And, perhaps most importantly, it forced healthcare leaders to see that there’s substantial risk within fee-for-service.
From a population health standpoint, the latter realization is hugely important. For five years, my firm’s annual State of Population Health survey of approximately 500 healthcare executives has found that providers are making very little progress toward improving population health – and in recent iterations, that that progress has altogether stalled.
Now, Covid-19 has brought us to a tipping point;...
Today's Sponsors
Today's Sponsor